A 42-state coalition, including Arizona, has settled with a biotechnology company over a data breach that exposed millions of customers’ genetic information nationwide.

Genetic testing company 23andMe has agreed to pay $18 million to settle claims from a coalition of 43 attorneys general that ...

Millions of former 23andMe customers are set to receive stronger privacy protections after the genetic testing company agreed to pay $18 million to settle claims over a massive data breach that ...

Texas AG Ken Paxton announced Wednesday that the state has joined a $150 million multistate settlement with genetic testing company 23andMe.

Vermont Business Magazine Attorney General Charity Clark today joined a coalition of 42 attorneys general in announcing a settlement with the bankruptcy trustee for 23andMe, resolving allegations ...

Forbes contributors publish independent expert analyses and insights. Digital forensics, AI, deepfakes, and what becomes proof in court. Regeneron Pharmaceuticals announced on Monday it will acquire ...

Interest in genetic data is on the rise, driven by the growth of direct-to-consumer (DTC) genetic testing and its value for AI in drug development and personalized medicine. Historically, gaps in ...

Press releases are posted on Independent.com as a free community service. OAKLAND — California Attorney General Rob Bonta today filed a lawsuit against Chrome Holding Co., formerly known as 23andMe, ...

In a Policy Forum, Natalie Ram and colleagues discuss the concerning gaps in robust regulatory protection on direct-to-consumer genetic data and biospecimens. After declaring bankruptcy in March 2025, ...

Add Yahoo as a preferred source to see more of our stories on Google. An archival U.S. Centers for Disease Control and Prevention photo shows a lab researcher reviewing the banding pattern from a DNA ...

Dozens of states have filed a joint lawsuit against the bankrupt DNA-testing company 23andMe to block the company’s sale of its customers’ genetic data without explicit consent. The suit, filed this ...

Regeneron Pharmaceuticals on Monday announced it is buying 23andMe out of bankruptcy for $256 million – taking with it the company’s extensive trove of genetic samples and data. It will acquire ...